NKRP1A molecule is involved in transendothelial migration of CD4+ human T lymphocytes. 1997

A Poggi, and P Costa, and M R Zocchi, and L Moretta
Istituto Nazionale per la Ricerca sul Cancro e Centro di Biotecnologie Avanzate, Genova, Italy.

Among human CD4+ T lymphocytes, 5-20% express the C-type lectin molecule NKRP1A. Interestingly, CD4+ NKRP1A+ T lymphocytes express high levels of beta 1 and beta 2 integrins, thus representing a T lymphocyte subset that can possibly adhere and migrate through vascular endothelium. Indeed, resting CD4+ NKRP1A+ lymphocytes, differently from the CD4+ NKRP1A- subset, migrated across endothelial cell monolayers in a Transwell chamber system. This transendothelial migration was strongly reduced after pre-treatment with an anti-NKRP1A monoclonal antibody (mAb). In addition, the NKRP1A negative Jurkatt CD4+ T-cell line that had been stably transfected with NKRP1A cDNA, migrated more rapidly and efficiently than untransfected Jurkatt cells. Finally, mAb-mediated cross-linking of NKRP1A molecule in CD4+ T lymphocytes induced the upregulation of the LFA1 Mg2+ binding site as well as beta 1 and beta 2 integrin chains. Altogether, these findings indicate that NKRP1A molecule is involved in transendothelial migration of resting CD4+ T lymphocytes.

UI MeSH Term Description Entries
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000954 Antigens, Surface Antigens on surfaces of cells, including infectious or foreign cells or viruses. They are usually protein-containing groups on cell membranes or walls and may be isolated. Cell Surface Antigens,Surface Antigens,Surface Markers, Immunological,Cell Surface Antigen,Immunologic Surface Markers,Markers, Immunological Surface,Surface Antigen,Surface Markers, Immunologic,Antigen, Cell Surface,Antigen, Surface,Antigens, Cell Surface,Immunological Surface Markers,Markers, Immunologic Surface,Surface Antigen, Cell,Surface Antigens, Cell
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte
D016169 Lymphocyte Function-Associated Antigen-1 An integrin heterodimer widely expressed on cells of hematopoietic origin. CD11A ANTIGEN comprises the alpha chain and the CD18 antigen (CD18 ANTIGENS) the beta chain. Lymphocyte function-associated antigen-1 is a major receptor of T-CELLS; B-CELLS; and GRANULOCYTES. It mediates the leukocyte adhesion reactions underlying cytolytic conjugate formation, helper T-cell interactions, and antibody-dependent killing by NATURAL KILLER CELLS and granulocytes. Intracellular adhesion molecule-1 has been defined as a ligand for lymphocyte function-associated antigen-1. LFA-1,Leukocyte Function Associated Antigen-1,Integrin alphaLbeta2,Antigen-1, Lymphocyte Function-Associated,Lymphocyte Function Associated Antigen 1,alphaLbeta2, Integrin
D055651 NK Cell Lectin-Like Receptor Subfamily B A subclass of NK cell lectin-like receptors that includes both inhibitory and stimulatory members. Antigens, CD161,CD161 Antigen,Killer Cell Lectin-Like Receptor Subfamily B,NK Cell Lectin-Like Receptor Subfamily B, Member 1,NKR-P1 Receptor,NKR-P1 Receptors,Receptors, NKR-P1,Antigen, CD161,CD161 Antigens,Killer Cell Lectin Like Receptor Subfamily B,NK Cell Lectin Like Receptor Subfamily B,NK Cell Lectin Like Receptor Subfamily B, Member 1,NKR P1 Receptor,NKR P1 Receptors,Receptor, NKR-P1,Receptors, NKR P1
D018821 CD18 Antigens Cell-surface glycoprotein beta-chains that are non-covalently linked to specific alpha-chains of the CD11 family of leukocyte-adhesion molecules (RECEPTORS, LEUKOCYTE-ADHESION). A defect in the gene encoding CD18 causes LEUKOCYTE-ADHESION DEFICIENCY SYNDROME. Antigens, CD18,Integrin beta2,CD18 Antigen,beta2 Integrin,p150,95 beta-Subunit,Integrin, beta2,beta-Subunit, p150,95,beta2, Integrin,p150,95 beta Subunit
D019012 Integrin beta1 Integrin beta chain expressed as a heterodimer that is non-covalently associated with specific alpha-chains of the CD49 family (CD49a-f). It is expressed on resting and activated leukocytes and is a marker for all of the very late activation antigens on cells. (from: Barclay et al., The Leukocyte Antigen FactsBook, 1993, p164) Antigens, CD29,CD29 Antigens,4B4 Antigen,CD29 Antigen,CDw29 Antigen,beta1 Integrin,Antigen, 4B4,Antigen, CD29,Antigen, CDw29,Integrin, beta1
D019169 Jurkat Cells A CELL LINE derived from human T-CELL LEUKEMIA and used to determine the mechanism of differential susceptibility to anti-cancer drugs and radiation. Cell, Jurkat,Cells, Jurkat,Jurkat Cell

Related Publications

A Poggi, and P Costa, and M R Zocchi, and L Moretta
September 2003, Journal of immunology (Baltimore, Md. : 1950),
A Poggi, and P Costa, and M R Zocchi, and L Moretta
January 2000, Anticancer research,
A Poggi, and P Costa, and M R Zocchi, and L Moretta
June 2007, Biochimica et biophysica acta,
A Poggi, and P Costa, and M R Zocchi, and L Moretta
January 1999, Journal of immunology (Baltimore, Md. : 1950),
A Poggi, and P Costa, and M R Zocchi, and L Moretta
November 1996, Scandinavian journal of immunology,
A Poggi, and P Costa, and M R Zocchi, and L Moretta
June 1994, Journal of immunology (Baltimore, Md. : 1950),
A Poggi, and P Costa, and M R Zocchi, and L Moretta
February 2011, Journal of immunology (Baltimore, Md. : 1950),
A Poggi, and P Costa, and M R Zocchi, and L Moretta
December 2014, Journal of immunology (Baltimore, Md. : 1950),
A Poggi, and P Costa, and M R Zocchi, and L Moretta
October 1995, American journal of therapeutics,
A Poggi, and P Costa, and M R Zocchi, and L Moretta
January 2007, European journal of immunology,
Copied contents to your clipboard!